Program
Cyclosporine
Also written as “cyclosporine”, “Cyclosporine A” and “Ciclosporin”.
Its studies are mostly in Dry Eye Syndromes · Dermatitis, Atopic · Bronchiolitis Obliterans Syndrome · Conjunctivitis, Allergic · Bronchiolitis Obliterans, led by 26 companies.
Drug pageCyclosporine: every studyMany companies study it; this page follows only the 81 they lead. All 388 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Novartisits history only | 220 open or running | phase 4since Sep 6, 2005 | Sep 6, 2005 | none ahead |
| Pfizer | 80 open or running | phase 4since Sep 13, 2005 | Jun 30, 2004 | none ahead |
| Hoffmann-La Rocheits history only | 70 open or running | phase 4since Jun 30, 2005 | Jun 30, 2005 | none ahead |
| Santen Pharmaceuticalits history only | 50 open or running | phase 3since May 19, 2006 | May 19, 2006 | none ahead |
| AbbVieits history only | 40 open or running | phase 4since Apr 22, 2014 | Apr 17, 2009 | none ahead |
| Zambon SpAits history only | 40 open or running | phase 3since Aug 30, 2018 | Aug 30, 2018 | none ahead |
| Sirion Therapeuticsits history only | 30 open or running | phase 3since Jul 13, 2007 | Jul 13, 2007 | none ahead |
| amsterdam-molecular-therapeuticsits history only | 20 open or running | phase 3since Apr 30, 2009 | Apr 30, 2009 | none ahead |
| apt-pharmaceuticals-incits history only | 20 open or running | phase 3since Sep 17, 2008 | Sep 17, 2008 | none ahead |
| Hanlim Pharm.its history only | 20 open or running | phase 3since Dec 10, 2012 | Dec 10, 2012 | none ahead |
| Innovative Medicalits history only | 20 open or running | phase 4since Jul 5, 2006 | Jul 5, 2006 | none ahead |
| Novaliqits history only | 20 open or running | phase 4since Mar 19, 2024 | Nov 25, 2015 | none ahead |
| perle-bioscience-incits history only | 20 open or running | phase 3since Jan 2, 2013 | Jan 2, 2013 | none ahead |
| Research Insightits history only | 20 open or running | phase 4since Apr 6, 2020 | Apr 6, 2020 | none ahead |
| sigmoid-pharmaits history only | 20 open or running | phase 2since Dec 15, 2009 | Dec 15, 2009 | none ahead |
| Sun Pharmaceutical Industriesits history only | 20 open or running | phase 4since Apr 8, 2020 | Feb 13, 2016 | none ahead |
| fovea-pharmaceuticals-saits history only | 10 open or running | phase 2since Apr 29, 2010 | Apr 29, 2010 | none ahead |
| isdinits history only | 10 open or running | phase 2since Dec 20, 2007 | Dec 20, 2007 | none ahead |
| LEO Pharmaits history only | 10 open or running | phase 4since Oct 16, 2018 | Oct 16, 2018 | none ahead |
| pari-pharma-gmbhits history only | 10 open or running | phase 3since Apr 11, 2011 | Apr 11, 2011 | none ahead |
| perioc-limitedits history only | 10 open or running | phase 2since Feb 12, 2015 | Feb 12, 2015 | none ahead |
| Pharming Groupits history only | 10 open or running | phase 1since Sep 11, 2012 | Sep 11, 2012 | none ahead |
| spherium-biomedits history only | 10 open or running | phase 2since Aug 4, 2016 | Aug 4, 2016 | none ahead |
| sublimity-therapeutics-holdco-limitedits history only | 10 open or running | phase 2since Jan 31, 2019 | Jan 31, 2019 | none ahead |
| Takedaits history only | 10 open or running | phase 3since Nov 1, 1999 | Nov 1, 1999 | none ahead |
| zhaoke-guangzhou-ophthalmology-pharmaceutical-ltdits history only | 11 open or running | phase 3since Jan 3, 2025 | Jan 3, 2025 | none ahead |
Also a collaborator on its studies: Parexel, Dr. Falk Pharma, Syreon and The Clinical Trial.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Pfizer only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jun 30, 2004First study: phase 3 study in Liver TransplantationFirst studyNCT00086346 · 607 enrolled · United States, Belgium, Canada and more
- Sep 9, 2005Phase 3 study in Renal InsufficiencyNCT00167947 · 150 enrolled · Italy
- Sep 13, 2005Phase 4 study in Renal InsufficiencyNCT00195468 · 280 enrolled · Brazil, Mexico
- Nov 4, 2005Phase 2 study in Kidney TransplantNCT00257387 · 120 enrolled
- Jan 25, 2007Phase 3 study in Renal TransplantationNCT00428064 · 408 enrolled
- Jul 26, 20072 phase 4 studies in Kidney TransplantationNCT00507793, NCT00518375
- May 3, 2012Phase 4 study in InflammationNCT01601821 · 245 enrolled · Iran, Islamic Republic of
TargetBeta
“Cyclophilin A modulator”ChEMBL 37, by rule
Studies
All 8 Pfizer leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT01601821Inflammation · Iran, Islamic Republic of | 4 | Completed | Mar 2008 | 245 |
| NCT00518375Kidney Transplantation | 4 | Completed | 250 | |
| NCT00507793Kidney Transplantation | 4 | Completed | 385 | |
| NCT00428064Renal Transplantation | 3 | Completed | 408 | |
| NCT00257387Kidney Transplant | 2 | Completed | 120 | |
| NCT00195468Renal Insufficiency · Brazil, Mexico | 4 | Completed | Nov 2006 | 280 |
| NCT00167947Renal Insufficiency · Italy | 3 | Completed | Jul 2007 | 150 |
| NCT00086346Liver Transplantation · United States, Belgium, Canada and more | 3 | Terminated | Jul 2008 | 607 |
How it is read
Names in the registry
- “cyclosporine”, 12 entries
- “Cyclosporine”, 10 entries
- “Cyclosporine A”, 6 entries
- “Ciclosporin”, 4 entries
- “Liposomal Cyclosporine A”, 3 entries
Codes read as this program: NOVA22007.
Conditions, from the studies’ own filings
- Dry Eye Syndromes, 15 studies
- Dermatitis, Atopic, 5 studies
- Bronchiolitis Obliterans Syndrome, 4 studies
- Conjunctivitis, Allergic, 4 studies
- Bronchiolitis Obliterans, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.